SGLT2 inhibition modulates metabolic, vascular, and inflammatory molecular markers in the kidney in youth with type 1 diabetes | Science Translational Medicine
Sequential kidney biopsies reveal that SGLT2 inhibitors reverse metabolic and inflammatory kidney dysregulation in youth with T1D.
